Regeneron price target raised to $824 from $641 at Leerink
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
REGN received an analyst target update from Leerink Partners.
Target: $824
Posted price: $803.48
Analyst firm: Leerink Partners
Analyst: David Risinger
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.